Kidney function, proteinuria and breast arterial calcification in women without clinical cardiovascular disease: The MINERVA study

被引:8
作者
Parikh, Rishi V. [1 ]
Iribarren, Carlos [1 ]
Lee, Catherine [1 ]
Levine-Hall, Tory [1 ]
Tan, Thida C. [1 ]
Sanchez, Gabriela [1 ]
Ding, Huanjun [2 ]
Bidgoli, Fatemeh Azamian [2 ]
Molloi, Sabee [2 ]
Go, Alan S. [1 ,3 ]
机构
[1] Kaiser Permanente Northern Calif, Div Res, Oakland, CA 94595 USA
[2] Univ Calif Irvine, Sch Med, Dept Radiat Sci, Irvine, CA 92717 USA
[3] Univ Calif San Francisco, Dept Epidemiol Biostat & Med, San Francisco, CA 94143 USA
关键词
BETA-ADRENERGIC ANTAGONISTS; VASCULAR CALCIFICATION; RISK-FACTORS; MEDIA CALCIFICATION; ATRIAL-FIBRILLATION; HEART-FAILURE; ADULTS; ANTICOAGULATION; THERAPY; DEATH;
D O I
10.1371/journal.pone.0210973
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Breast arterial calcification (BAC) may be a predictor of cardiovascular events and is highly prevalent in persons with end-stage kidney disease. However, few studies to date have examined the association between mild-to-moderate kidney function and proteinuria with BAC. Methods We prospectively enrolled women with no prior cardiovascular disease aged 60 to 79 years undergoing mammography screening at Kaiser Permanente Northern California between 10/24/2012 and 2/13/2015. Urine albumin-to-creatinine ratio (uACR), along with specific laboratory, demographic, and medical data, were measured at the baseline visit. Baseline estimated glomerular filtration rate (eGFR), medication history, and other comorbidities were identified from self-report and/or electronic medical records. BAC presence and gradation (mass) was measured by digital quantification of full-field mammograms. Results Among 3,507 participants, 24.5% were aged >= 70 years, 63.5% were white, 7.5% had eGFR <60 ml/min/1.73m(2), with 85.7% having uACR >= 30 mg/g and 3.3% having uACR >= 300 mg/g. The prevalence of any measured BAC (>0 mg) was 27.9%. Neither uACR >= 30 mg/g nor uACR >= 300 were significantly associated with BAC in crude or multivariable analyses. Reduced eGFR was associated with BAC in univariate analyses (odds ratio 1.53, 95% CI: 1.18-2.00), but the association was no longer significant after adjustment for potential confounders. Results were similar in various sensitivity analyses that used different BAC thresholds or analytic approaches. Conclusions Among women without cardiovascular disease undergoing mammography screening, reduced eGFR and albuminuria were not significantly associated with BAC.
引用
收藏
页数:16
相关论文
共 40 条
[1]   The Risk for Medial Arterial Calcification in CKD [J].
Abou Hassan, Nada ;
D'Orsi, Ellen T. ;
D'Orsi, Carl J. ;
O'Neil, W. Charles .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (02) :275-279
[2]   Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease [J].
Amann, Kerstin .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06) :1599-1605
[3]   Do breast arterial calcifications on mammography predict elevated risk of coronary artery disease? [J].
Chadashvili, Tamuna ;
Litmanovich, Diana ;
Hall, Ferris ;
Slanetz, Priscilla J. .
EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (06) :1121-1124
[4]   Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease [J].
Chen, Jing ;
Budoff, Matthew J. ;
Reilly, Muredach P. ;
Yang, Wei ;
Rosas, Sylvia E. ;
Rahman, Mahboob ;
Zhang, Xiaoming ;
Roy, Jason A. ;
Lustigova, Eva ;
Nessel, Lisa ;
Ford, Virginia ;
Raj, Dominic ;
Porter, Anna C. ;
Soliman, Elsayed Z. ;
Wright, Jackson T., Jr. ;
Wolf, Myles ;
He, Jiang .
JAMA CARDIOLOGY, 2017, 2 (06) :635-643
[5]  
de Oliveira Rodrigo Bueno, 2013, J Bras Nefrol, V35, P147, DOI 10.5935/0101-2800.20130024
[6]   Breast Arterial Calcification: A Marker of Medial Vascular Calcification in Chronic Kidney Disease [J].
Duhn, Valerie ;
D'Orsi, Ellen T. ;
Johnson, Samuel ;
D'Orsi, Carl J. ;
Adams, Amy L. ;
O'Neill, W. Charles .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (02) :377-382
[7]   Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure [J].
Go, Alan S. ;
Yang, Jingrong ;
Gurwitz, Jerry H. ;
Hsu, John ;
Lane, Kimberly ;
Platt, Richard .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (04) :690-696
[8]   Statin therapy and risks for death and hospitalization in chronic heart failure [J].
Go, Alan S. ;
Lee, Wendy Y. ;
Yang, Jingrong ;
Lo, Joan C. ;
Gurwitz, Jerry H. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (17) :2105-2111
[9]   Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure - The anemia in chronic heart failure: Outcomes and Resource Utilization (ANCHOR) Study [J].
Go, Alan S. ;
Yang, Jingrong ;
Ackerson, Lynn M. ;
Lepper, Krista ;
Robbins, Sean ;
Massie, Barry M. ;
Shlipak, Michael G. .
CIRCULATION, 2006, 113 (23) :2713-2723
[10]   The Cardiovascular Research Network A New Paradigm for Cardiovascular Quality and Outcomes Research [J].
Go, Alan S. ;
Magid, David J. ;
Wells, Barbara ;
Sung, Sue Hee ;
Cassidy-Bushrow, Andrea E. ;
Greenlee, Robert T. ;
Langer, Robert D. ;
Lieu, Tracy A. ;
Margolis, Karen L. ;
Masoudi, Frederick A. ;
McNeal, Catherine J. ;
Murata, Glen H. ;
Newton, Katherine M. ;
Novotny, Rachel ;
Reynolds, Kristi ;
Roblin, Douglas W. ;
Smith, David H. ;
Vupputuri, Suma ;
White, Robert E. ;
Olson, Jean ;
Rumsfeld, John S. ;
Gurwitz, Jerry H. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2008, 1 (02) :138-147